nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—Ventricular fibrillation—Ifosfamide—testicular cancer	0.024	0.024	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Vinblastine—testicular cancer	0.0189	0.0189	CcSEcCtD
Methylergometrine—Ventricular tachycardia—Ifosfamide—testicular cancer	0.0184	0.0184	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Bleomycin—testicular cancer	0.0159	0.0159	CcSEcCtD
Methylergometrine—Angina pectoris—Vinblastine—testicular cancer	0.0156	0.0156	CcSEcCtD
Methylergometrine—Thrombophlebitis—Ifosfamide—testicular cancer	0.0154	0.0154	CcSEcCtD
Methylergometrine—Hallucination—Chlorambucil—testicular cancer	0.0139	0.0139	CcSEcCtD
Methylergometrine—Nasal congestion—Cisplatin—testicular cancer	0.0126	0.0126	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Cisplatin—testicular cancer	0.0117	0.0117	CcSEcCtD
Methylergometrine—Haematuria—Bleomycin—testicular cancer	0.0115	0.0115	CcSEcCtD
Methylergometrine—Angina pectoris—Ifosfamide—testicular cancer	0.0112	0.0112	CcSEcCtD
Methylergometrine—Convulsion—Chlorambucil—testicular cancer	0.0105	0.0105	CcSEcCtD
Methylergometrine—Haematuria—Ifosfamide—testicular cancer	0.00981	0.00981	CcSEcCtD
Methylergometrine—Sweating increased—Cisplatin—testicular cancer	0.00969	0.00969	CcSEcCtD
Methylergometrine—Convulsion—Vinblastine—testicular cancer	0.00965	0.00965	CcSEcCtD
Methylergometrine—Hypertension—Vinblastine—testicular cancer	0.00962	0.00962	CcSEcCtD
Methylergometrine—Bradycardia—Ifosfamide—testicular cancer	0.0094	0.0094	CcSEcCtD
Methylergometrine—Hallucination—Ifosfamide—testicular cancer	0.00919	0.00919	CcSEcCtD
Methylergometrine—Sweating increased—Etoposide—testicular cancer	0.00888	0.00888	CcSEcCtD
Methylergometrine—Tinnitus—Ifosfamide—testicular cancer	0.00861	0.00861	CcSEcCtD
Methylergometrine—Cardiac disorder—Ifosfamide—testicular cancer	0.00857	0.00857	CcSEcCtD
Methylergometrine—Atrioventricular block—Epirubicin—testicular cancer	0.00839	0.00839	CcSEcCtD
Methylergometrine—Paraesthesia—Vinblastine—testicular cancer	0.00816	0.00816	CcSEcCtD
Methylergometrine—Ventricular tachycardia—Epirubicin—testicular cancer	0.00814	0.00814	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Chlorambucil—testicular cancer	0.00811	0.00811	CcSEcCtD
Methylergometrine—Bradycardia—Cisplatin—testicular cancer	0.00811	0.00811	CcSEcCtD
Methylergometrine—Chest pain—Bleomycin—testicular cancer	0.00801	0.00801	CcSEcCtD
Methylergometrine—Abdominal pain—Chlorambucil—testicular cancer	0.00784	0.00784	CcSEcCtD
Methylergometrine—Atrioventricular block—Doxorubicin—testicular cancer	0.00777	0.00777	CcSEcCtD
Methylergometrine—Anaphylactic shock—Bleomycin—testicular cancer	0.00768	0.00768	CcSEcCtD
Methylergometrine—Ventricular tachycardia—Doxorubicin—testicular cancer	0.00753	0.00753	CcSEcCtD
Methylergometrine—Cramps of lower extremities—Epirubicin—testicular cancer	0.00748	0.00748	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Vinblastine—testicular cancer	0.00743	0.00743	CcSEcCtD
Methylergometrine—Tinnitus—Cisplatin—testicular cancer	0.00742	0.00742	CcSEcCtD
Methylergometrine—Cardiac disorder—Cisplatin—testicular cancer	0.00739	0.00739	CcSEcCtD
Methylergometrine—Thrombophlebitis—Methotrexate—testicular cancer	0.0073	0.0073	CcSEcCtD
Methylergometrine—Abdominal pain—Vinblastine—testicular cancer	0.00719	0.00719	CcSEcCtD
Methylergometrine—Hypotension—Bleomycin—testicular cancer	0.00717	0.00717	CcSEcCtD
Methylergometrine—Palpitations—Ifosfamide—testicular cancer	0.00711	0.00711	CcSEcCtD
Methylergometrine—Convulsion—Ifosfamide—testicular cancer	0.00697	0.00697	CcSEcCtD
Methylergometrine—Hypertension—Ifosfamide—testicular cancer	0.00694	0.00694	CcSEcCtD
Methylergometrine—Cramps of lower extremities—Doxorubicin—testicular cancer	0.00692	0.00692	CcSEcCtD
Methylergometrine—Paraesthesia—Bleomycin—testicular cancer	0.00689	0.00689	CcSEcCtD
Methylergometrine—Dyspnoea—Bleomycin—testicular cancer	0.00685	0.00685	CcSEcCtD
Methylergometrine—Chest pain—Ifosfamide—testicular cancer	0.00684	0.00684	CcSEcCtD
Methylergometrine—Thrombophlebitis—Epirubicin—testicular cancer	0.00683	0.00683	CcSEcCtD
Methylergometrine—Diarrhoea—Chlorambucil—testicular cancer	0.00679	0.00679	CcSEcCtD
Methylergometrine—Cardiac disorder—Etoposide—testicular cancer	0.00677	0.00677	CcSEcCtD
Methylergometrine—Muscle spasms—Cisplatin—testicular cancer	0.00666	0.00666	CcSEcCtD
Methylergometrine—Anaphylactic shock—Ifosfamide—testicular cancer	0.00656	0.00656	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Methotrexate—testicular cancer	0.00645	0.00645	CcSEcCtD
Methylergometrine—Nervous system disorder—Ifosfamide—testicular cancer	0.00643	0.00643	CcSEcCtD
Methylergometrine—Hyperhidrosis—Ifosfamide—testicular cancer	0.00634	0.00634	CcSEcCtD
Methylergometrine—Thrombophlebitis—Doxorubicin—testicular cancer	0.00632	0.00632	CcSEcCtD
Methylergometrine—Vomiting—Chlorambucil—testicular cancer	0.00631	0.00631	CcSEcCtD
Methylergometrine—Diarrhoea—Vinblastine—testicular cancer	0.00622	0.00622	CcSEcCtD
Methylergometrine—Hypotension—Ifosfamide—testicular cancer	0.00613	0.00613	CcSEcCtD
Methylergometrine—Muscle spasms—Etoposide—testicular cancer	0.00611	0.00611	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Epirubicin—testicular cancer	0.00603	0.00603	CcSEcCtD
Methylergometrine—Dizziness—Vinblastine—testicular cancer	0.00601	0.00601	CcSEcCtD
Methylergometrine—Convulsion—Cisplatin—testicular cancer	0.00601	0.00601	CcSEcCtD
Methylergometrine—Nausea—Chlorambucil—testicular cancer	0.00589	0.00589	CcSEcCtD
Methylergometrine—Paraesthesia—Ifosfamide—testicular cancer	0.00589	0.00589	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00586	0.00586	CcSEcCtD
Methylergometrine—Dyspnoea—Ifosfamide—testicular cancer	0.00585	0.00585	CcSEcCtD
Methylergometrine—Vomiting—Vinblastine—testicular cancer	0.00578	0.00578	CcSEcCtD
Methylergometrine—Headache—Vinblastine—testicular cancer	0.00569	0.00569	CcSEcCtD
Methylergometrine—Abdominal pain—Dactinomycin—testicular cancer	0.00566	0.00566	CcSEcCtD
Methylergometrine—Anaphylactic shock—Cisplatin—testicular cancer	0.00566	0.00566	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Doxorubicin—testicular cancer	0.00558	0.00558	CcSEcCtD
Methylergometrine—Nervous system disorder—Cisplatin—testicular cancer	0.00555	0.00555	CcSEcCtD
Methylergometrine—Tachycardia—Cisplatin—testicular cancer	0.00552	0.00552	CcSEcCtD
Methylergometrine—Convulsion—Etoposide—testicular cancer	0.0055	0.0055	CcSEcCtD
Methylergometrine—Hypertension—Etoposide—testicular cancer	0.00548	0.00548	CcSEcCtD
Methylergometrine—Hyperhidrosis—Cisplatin—testicular cancer	0.00547	0.00547	CcSEcCtD
Methylergometrine—Chest pain—Etoposide—testicular cancer	0.00541	0.00541	CcSEcCtD
Methylergometrine—Nausea—Vinblastine—testicular cancer	0.0054	0.0054	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00537	0.00537	CcSEcCtD
Methylergometrine—Hypotension—Cisplatin—testicular cancer	0.00529	0.00529	CcSEcCtD
Methylergometrine—Abdominal pain—Ifosfamide—testicular cancer	0.00519	0.00519	CcSEcCtD
Methylergometrine—Anaphylactic shock—Etoposide—testicular cancer	0.00518	0.00518	CcSEcCtD
Methylergometrine—Paraesthesia—Cisplatin—testicular cancer	0.00508	0.00508	CcSEcCtD
Methylergometrine—Tachycardia—Etoposide—testicular cancer	0.00506	0.00506	CcSEcCtD
Methylergometrine—Dyspnoea—Cisplatin—testicular cancer	0.00504	0.00504	CcSEcCtD
Methylergometrine—Hyperhidrosis—Etoposide—testicular cancer	0.00501	0.00501	CcSEcCtD
Methylergometrine—Angina pectoris—Epirubicin—testicular cancer	0.00498	0.00498	CcSEcCtD
Methylergometrine—Diarrhoea—Dactinomycin—testicular cancer	0.0049	0.0049	CcSEcCtD
Methylergometrine—Vomiting—Bleomycin—testicular cancer	0.00488	0.00488	CcSEcCtD
Methylergometrine—Hypotension—Etoposide—testicular cancer	0.00484	0.00484	CcSEcCtD
Methylergometrine—Rash—Bleomycin—testicular cancer	0.00484	0.00484	CcSEcCtD
Methylergometrine—Dermatitis—Bleomycin—testicular cancer	0.00484	0.00484	CcSEcCtD
Methylergometrine—Paraesthesia—Etoposide—testicular cancer	0.00465	0.00465	CcSEcCtD
Methylergometrine—Haematuria—Methotrexate—testicular cancer	0.00464	0.00464	CcSEcCtD
Methylergometrine—Dyspnoea—Etoposide—testicular cancer	0.00462	0.00462	CcSEcCtD
Methylergometrine—Angina pectoris—Doxorubicin—testicular cancer	0.0046	0.0046	CcSEcCtD
Methylergometrine—Nausea—Bleomycin—testicular cancer	0.00456	0.00456	CcSEcCtD
Methylergometrine—Vomiting—Dactinomycin—testicular cancer	0.00455	0.00455	CcSEcCtD
Methylergometrine—Rash—Dactinomycin—testicular cancer	0.00451	0.00451	CcSEcCtD
Methylergometrine—Diarrhoea—Ifosfamide—testicular cancer	0.00449	0.00449	CcSEcCtD
Methylergometrine—Haematuria—Epirubicin—testicular cancer	0.00434	0.00434	CcSEcCtD
Methylergometrine—Dizziness—Ifosfamide—testicular cancer	0.00434	0.00434	CcSEcCtD
Methylergometrine—Nausea—Dactinomycin—testicular cancer	0.00425	0.00425	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Etoposide—testicular cancer	0.00424	0.00424	CcSEcCtD
Methylergometrine—Vomiting—Ifosfamide—testicular cancer	0.00417	0.00417	CcSEcCtD
Methylergometrine—Bradycardia—Epirubicin—testicular cancer	0.00416	0.00416	CcSEcCtD
Methylergometrine—Rash—Ifosfamide—testicular cancer	0.00414	0.00414	CcSEcCtD
Methylergometrine—Dermatitis—Ifosfamide—testicular cancer	0.00413	0.00413	CcSEcCtD
Methylergometrine—Abdominal pain—Etoposide—testicular cancer	0.0041	0.0041	CcSEcCtD
Methylergometrine—Tinnitus—Methotrexate—testicular cancer	0.00407	0.00407	CcSEcCtD
Methylergometrine—Cardiac disorder—Methotrexate—testicular cancer	0.00406	0.00406	CcSEcCtD
Methylergometrine—Haematuria—Doxorubicin—testicular cancer	0.00402	0.00402	CcSEcCtD
Methylergometrine—Nausea—Ifosfamide—testicular cancer	0.0039	0.0039	CcSEcCtD
Methylergometrine—Diarrhoea—Cisplatin—testicular cancer	0.00387	0.00387	CcSEcCtD
Methylergometrine—Bradycardia—Doxorubicin—testicular cancer	0.00385	0.00385	CcSEcCtD
Methylergometrine—Tinnitus—Epirubicin—testicular cancer	0.00381	0.00381	CcSEcCtD
Methylergometrine—Cardiac disorder—Epirubicin—testicular cancer	0.00379	0.00379	CcSEcCtD
Methylergometrine—Vomiting—Cisplatin—testicular cancer	0.0036	0.0036	CcSEcCtD
Methylergometrine—Rash—Cisplatin—testicular cancer	0.00357	0.00357	CcSEcCtD
Methylergometrine—Dermatitis—Cisplatin—testicular cancer	0.00356	0.00356	CcSEcCtD
Methylergometrine—Diarrhoea—Etoposide—testicular cancer	0.00355	0.00355	CcSEcCtD
Methylergometrine—Tinnitus—Doxorubicin—testicular cancer	0.00353	0.00353	CcSEcCtD
Methylergometrine—Cardiac disorder—Doxorubicin—testicular cancer	0.00351	0.00351	CcSEcCtD
Methylergometrine—Dizziness—Etoposide—testicular cancer	0.00343	0.00343	CcSEcCtD
Methylergometrine—Muscle spasms—Epirubicin—testicular cancer	0.00342	0.00342	CcSEcCtD
Methylergometrine—Nausea—Cisplatin—testicular cancer	0.00336	0.00336	CcSEcCtD
Methylergometrine—Convulsion—Methotrexate—testicular cancer	0.0033	0.0033	CcSEcCtD
Methylergometrine—Vomiting—Etoposide—testicular cancer	0.0033	0.0033	CcSEcCtD
Methylergometrine—Rash—Etoposide—testicular cancer	0.00327	0.00327	CcSEcCtD
Methylergometrine—Dermatitis—Etoposide—testicular cancer	0.00326	0.00326	CcSEcCtD
Methylergometrine—Headache—Etoposide—testicular cancer	0.00325	0.00325	CcSEcCtD
Methylergometrine—Chest pain—Methotrexate—testicular cancer	0.00324	0.00324	CcSEcCtD
Methylergometrine—Muscle spasms—Doxorubicin—testicular cancer	0.00317	0.00317	CcSEcCtD
Methylergometrine—Palpitations—Epirubicin—testicular cancer	0.00315	0.00315	CcSEcCtD
Methylergometrine—Anaphylactic shock—Methotrexate—testicular cancer	0.0031	0.0031	CcSEcCtD
Methylergometrine—Convulsion—Epirubicin—testicular cancer	0.00308	0.00308	CcSEcCtD
Methylergometrine—Nausea—Etoposide—testicular cancer	0.00308	0.00308	CcSEcCtD
Methylergometrine—Hypertension—Epirubicin—testicular cancer	0.00307	0.00307	CcSEcCtD
Methylergometrine—Nervous system disorder—Methotrexate—testicular cancer	0.00304	0.00304	CcSEcCtD
Methylergometrine—Chest pain—Epirubicin—testicular cancer	0.00303	0.00303	CcSEcCtD
Methylergometrine—Hyperhidrosis—Methotrexate—testicular cancer	0.003	0.003	CcSEcCtD
Methylergometrine—Palpitations—Doxorubicin—testicular cancer	0.00291	0.00291	CcSEcCtD
Methylergometrine—Anaphylactic shock—Epirubicin—testicular cancer	0.00291	0.00291	CcSEcCtD
Methylergometrine—Hypotension—Methotrexate—testicular cancer	0.0029	0.0029	CcSEcCtD
Methylergometrine—Convulsion—Doxorubicin—testicular cancer	0.00285	0.00285	CcSEcCtD
Methylergometrine—Nervous system disorder—Epirubicin—testicular cancer	0.00285	0.00285	CcSEcCtD
Methylergometrine—Hypertension—Doxorubicin—testicular cancer	0.00284	0.00284	CcSEcCtD
Methylergometrine—Tachycardia—Epirubicin—testicular cancer	0.00284	0.00284	CcSEcCtD
Methylergometrine—Hyperhidrosis—Epirubicin—testicular cancer	0.00281	0.00281	CcSEcCtD
Methylergometrine—Chest pain—Doxorubicin—testicular cancer	0.0028	0.0028	CcSEcCtD
Methylergometrine—Paraesthesia—Methotrexate—testicular cancer	0.00279	0.00279	CcSEcCtD
Methylergometrine—Dyspnoea—Methotrexate—testicular cancer	0.00277	0.00277	CcSEcCtD
Methylergometrine—Hypotension—Epirubicin—testicular cancer	0.00271	0.00271	CcSEcCtD
Methylergometrine—Anaphylactic shock—Doxorubicin—testicular cancer	0.00269	0.00269	CcSEcCtD
Methylergometrine—Nervous system disorder—Doxorubicin—testicular cancer	0.00264	0.00264	CcSEcCtD
Methylergometrine—Tachycardia—Doxorubicin—testicular cancer	0.00262	0.00262	CcSEcCtD
Methylergometrine—Paraesthesia—Epirubicin—testicular cancer	0.00261	0.00261	CcSEcCtD
Methylergometrine—Hyperhidrosis—Doxorubicin—testicular cancer	0.0026	0.0026	CcSEcCtD
Methylergometrine—Dyspnoea—Epirubicin—testicular cancer	0.00259	0.00259	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Methotrexate—testicular cancer	0.00254	0.00254	CcSEcCtD
Methylergometrine—Hypotension—Doxorubicin—testicular cancer	0.00251	0.00251	CcSEcCtD
Methylergometrine—Abdominal pain—Methotrexate—testicular cancer	0.00245	0.00245	CcSEcCtD
Methylergometrine—Paraesthesia—Doxorubicin—testicular cancer	0.00241	0.00241	CcSEcCtD
Methylergometrine—Dyspnoea—Doxorubicin—testicular cancer	0.0024	0.0024	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Epirubicin—testicular cancer	0.00238	0.00238	CcSEcCtD
Methylergometrine—Abdominal pain—Epirubicin—testicular cancer	0.0023	0.0023	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.0022	0.0022	CcSEcCtD
Methylergometrine—Abdominal pain—Doxorubicin—testicular cancer	0.00212	0.00212	CcSEcCtD
Methylergometrine—Diarrhoea—Methotrexate—testicular cancer	0.00212	0.00212	CcSEcCtD
Methylergometrine—Dizziness—Methotrexate—testicular cancer	0.00205	0.00205	CcSEcCtD
Methylergometrine—Diarrhoea—Epirubicin—testicular cancer	0.00199	0.00199	CcSEcCtD
Methylergometrine—Vomiting—Methotrexate—testicular cancer	0.00197	0.00197	CcSEcCtD
Methylergometrine—Rash—Methotrexate—testicular cancer	0.00196	0.00196	CcSEcCtD
Methylergometrine—Dermatitis—Methotrexate—testicular cancer	0.00196	0.00196	CcSEcCtD
Methylergometrine—Headache—Methotrexate—testicular cancer	0.00194	0.00194	CcSEcCtD
Methylergometrine—Dizziness—Epirubicin—testicular cancer	0.00192	0.00192	CcSEcCtD
Methylergometrine—Vomiting—Epirubicin—testicular cancer	0.00185	0.00185	CcSEcCtD
Methylergometrine—Nausea—Methotrexate—testicular cancer	0.00184	0.00184	CcSEcCtD
Methylergometrine—Diarrhoea—Doxorubicin—testicular cancer	0.00184	0.00184	CcSEcCtD
Methylergometrine—Rash—Epirubicin—testicular cancer	0.00183	0.00183	CcSEcCtD
Methylergometrine—Dermatitis—Epirubicin—testicular cancer	0.00183	0.00183	CcSEcCtD
Methylergometrine—Headache—Epirubicin—testicular cancer	0.00182	0.00182	CcSEcCtD
Methylergometrine—Dizziness—Doxorubicin—testicular cancer	0.00178	0.00178	CcSEcCtD
Methylergometrine—Nausea—Epirubicin—testicular cancer	0.00173	0.00173	CcSEcCtD
Methylergometrine—Vomiting—Doxorubicin—testicular cancer	0.00171	0.00171	CcSEcCtD
Methylergometrine—Rash—Doxorubicin—testicular cancer	0.00169	0.00169	CcSEcCtD
Methylergometrine—Dermatitis—Doxorubicin—testicular cancer	0.00169	0.00169	CcSEcCtD
Methylergometrine—Headache—Doxorubicin—testicular cancer	0.00168	0.00168	CcSEcCtD
Methylergometrine—Nausea—Doxorubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
